# Masco Corporation (MAS) fundamentals

Data as of 2026-11-04. NYSE, United States. Sector: Industrials / Building Products. Price $82.18, market value $15.8 billion.

## Valuation
- **P/E (trailing): 18.1×** (5-yr avg 20.6×, 3-yr avg 17.0×). Masco Corporation trades at 18.1× trailing earnings, close to its own five-year average of 20.6×. The Industrials median in the September 2026 study was 25.7×. Forward P/E is 17.5×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 6.57**. A PEG of 6.57 means the P/E is high relative to expected earnings growth; the price already assumes a lot.
- **Price / sales: 2.1×**. Each dollar of revenue is priced at 2.1×.
- **EV / EBITDA: 11.9×**. Enterprise value is 11.9× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Free-cash-flow yield: 6.6%** (5-yr avg 6.3%). Free cash flow equals 6.6% of the market value, in line with its five-year average of 6.3%. Above 5% is generally attractive.
- **Earnings yield: 5.5%**. The inverse of the P/E: 5.5% of the price is earned each year.

## Profitability
- **Gross margin: 37.6%**. Masco Corporation keeps 37.6% of revenue after the direct cost of what it sells.
- **Operating margin: 17.9%**. 17.9% of revenue is left after running the business, a healthy level in most sectors.
- **Net margin: 10.7%**. 10.7% of each dollar of sales reaches the bottom line.
- **Return on equity: -437.8%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: 51.3%**. Return on all capital, debt included, is 51.3%: comfortably above what that capital costs.
- **Return on assets: 17.8%**. Each dollar of assets produces 17.8% of profit.

## Growth
- **Revenue growth (1 yr): -3.4%** (3-yr -4.5%/yr, 5-yr 1.0%/yr). Revenue fell 3.4% over the last year, against 1.0% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 2.7%** (3-yr 2.1%/yr, 5-yr -3.4%/yr). Earnings per share rose 2.7%, faster than revenue, so margins expanded or the share count shrank.
- **Free-cash-flow growth (3 yr): 12.0%/yr**. Free cash flow has compounded at 12.0% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Net debt / EBITDA: 1.5×**. It would take 1.5 years of operating earnings to repay net borrowings, within the comfortable range.
- **Current ratio: 1.81** (quick 1.81). Current assets cover the next year's liabilities 1.81 times.
- **Altman Z-score: 4.34**. A Z-score of 4.34 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 1.56%** ($1.27 per share, trailing). Masco Corporation yields 1.56%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 32%** (24% of free cash flow). 32% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 15**. 15 straight years of increases, a record that survived at least one recession.
- **Dividend growth (5 yr): 17.9%/yr** (1-yr 6.9%). The dividend has compounded at 17.9% a year over five years, doubling roughly every 4 years at that pace.

## Analyst view
- **Analyst consensus: buy** (19 analysts). 19 analysts cover Masco Corporation; the consensus is buy, with an average price target of $82.53 (+0% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 30.8%** (YTD 32.8%, 3-mo 11.7%). The shares are up 30.8% over twelve months including dividends.
- **From 52-week high: -2.0%** (41.3% above the low). Trading within 5% of its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 78**. An RSI of 78 is in overbought territory; short-term pullbacks are common from here.
- **Beta (1 yr): 1.05** (volatility 36%). Beta of 1.05 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=MAS · Page: https://foliofundamentals.com/stocks/mas

Not investment advice.